Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
Patrick Conway, MD, MSc, Chief Medical Officer Policy Division for the Secretary of Health and Human Services, Executive Director Federal Coordinating Council for Comparative-Effectiveness Research at Health and…
Patrick Conway, MD, MSc, Chief Medical Officer Policy Division for the Secretary of Health and Human Services, Executive Director Federal Coordinating Council for Comparative-Effectiveness Research at Health and…
Robert Shorr, Ph.D, D.I.C, CEO, Cornerstone Pharmaceuticals, discusses how physicians can understand a new oncology drug, starting with knowing its safety limitations. He also explains the structure and…
Andrew Hecht MD, Co-chief, Spine Surgery, Assistant Professor of Orthopedics and Neurosurgery, Mount Sinai Medical Center, discusses spinal injuries in athletes such as NFL players, and treatment options…
Andrew Hecht MD, Co-chief, Spine Surgery, Assistant Professor of Orthopedics and Neurosurgery, Mount Sinai Medical Center, discusses the 3 basic types of neck problems he sees as a…
E. Murat Tuzcu, MD, Professor of Medicine, Cleveland Clinic, discusses the current limitations of catheter-based valve replacements, including problems with the femoral artery route and atherosclerosis and paravalvular…
Imad Najm, MD, Director, Epilepsy Center, Cleveland Clinic, discusses SEEG or Stereo Encephalography for Epilepsy, a new minimally invasive procedure used to localize the areas of seizure onset.…
Gary Falk, MD, MS, Professor of Medicine, Director, Center for Esophageal and Swallowing Disorders, Cleveland Clinic, discusses a new treatment Barrett’s esophagus, radiofrequency ablation, useful in two particular…
NEW YORK (Reuters Health) – An “important” relation exists between platelet reactivity and glycemic control in patients with type 2 diabetes and coronary artery disease who are on…
